Daily round-up, Aug 29: New work pass to draw top talent to Singapore; first day of eased indoor mask restrictions; Shenzhen shuts key electronics market to fight COVID-19

By:
On:
In: Asia

Let’s get you up to speed with the day’s stories. A work pass is being introduced that will allow high-earners and high-achievers to live in Singapore without having to secure a job here first. The Overseas Networks & Expertise Pass is meant for talent from any sector who earns aContinue Reading

DPM Heng, CE John Lee reaffirm ‘good momentum’ of longstanding partnership between Singapore and Hong Kong

By:
On:
In: South-East Asia

SINGAPORE: Deputy Prime Minister Heng Swee Keat and Chief Executive John Lee reaffirmed the longstanding partnership between Singapore and Hong Kong during their meeting on Monday (Aug 29). In a Facebook post after their meeting, Mr Heng wrote: “As cities with international outlooks, Hong Kong and Singapore have very muchContinue Reading

Fujifilm chasing Samsung, WuXi with big biopharma plans

By:
On:
In: Asia

TOKYO – Japan’s Fujifilm has announced plans to invest approximately 200 billion yen (US$1.45 billion) to expand its biopharmaceutical production capacity by 3.7 times over the next five years.

Management expects this to support a 3.3 times increase in annual Bio-CDMO revenue to 500 billion yen ($3.7 billion) by the end of the decade. Bio-CDMO is short for Biologics Contract Development and Manufacturing Organization – an organization that serves pharmaceutical companies that cannot afford to or prefer not to invest in their own production facilities.

Fujifilm is the third East Asian CDMO to announce a major expansion plan, the others being China’s WuXi Biologics and South Korea’s Samsung Biologics. By the end of the decade, these and other East Asian companies are likely to have a defining presence in the industry.

The 200 billion yen will be spent on a new building, bioreactors, purification facilities and other equipment at the company’s manufacturing complex in Denmark, making it the largest end-to-end CDMO facility in Europe.

To continue reading, please log in to your AT+ Premium account. Not yet a member? Please signup for AT+ Premium monthly membership, AT+ Premium yearly membership, AT+ Premium yearly membership (educator), AT+ Premium yearly membership (student) or AT+ Premium Access membership.

The post Fujifilm chasing Samsung, WuXi with big biopharma plans appeared first on Asia Times.

Continue Reading